Table 3.
Final multivariable models for pathogen seropositivity.
| Pathogen | Variable | OR | p | 95% CI | ||
|---|---|---|---|---|---|---|
| CRCoV (N = 496) | Country | Italy | Ref | |||
| Greece | 1.6 | 0.126 | 0.87 | 2.97 | ||
| Hungary | 1.4 | 0.331 | 0.73 | 2.51 | ||
| France | 4.8 | <0.001 | 2.34 | 9.69 | ||
| Spain | 4.1 | <0.001 | 2.06 | 8.34 | ||
| Netherlands | 1.5 | 0.289 | 0.72 | 3.00 | ||
| CnPnV IgG | Negative | Ref | ||||
| Positive | 2.7 | <0.001 | 1.77 | 4.00 | ||
| Age | 1.1 | 0.001 | 1.04 | 1.17 | ||
| CnPnV (N = 525) | Country | Italy | Ref | |||
| Greece | 1.4 | 0.331 | 0.71 | 2.81 | ||
| Hungary | 1.6 | 0.151 | 0.83 | 3.17 | ||
| France | 3.4 | 0.001 | 1.67 | 6.93 | ||
| Spain | 1.7 | 0.192 | 0.75 | 3.92 | ||
| Netherlands | 3.7 | 0.002 | 1.64 | 8.22 | ||
| Source | Client | Ref | ||||
| Shelter | 2.8 | <0.001 | 1.61 | 4.87 | ||
| Other | 8.0 | <0.001 | 3.33 | 19.26 | ||
| CRCoV IgG | Negative | Ref | ||||
| Positive | 2.7 | <0.001 | 1.79 | 4.08 | ||
| M. cynos IgG | Negative | Ref | ||||
| Positive | 1.8 | 0.005 | 1.20 | 2.76 | ||
| M. cynos (N = 496) | Country | Italy | Ref | |||
| Greece | 2.3 | 0.008 | 1.23 | 4.16 | ||
| Hungary | 1.6 | 0.171 | 0.82 | 3.03 | ||
| France | 2.5 | 0.012 | 1.22 | 5.27 | ||
| Spain | 2.2 | 0.028 | 1.08 | 4.46 | ||
| Netherlands | 0.7 | 0.334 | 0.29 | 1.51 | ||
| Source | Client | Ref | ||||
| Shelter | 1.8 | 0.024 | 1.08 | 3.15 | ||
| Other | 0.5 | 0.126 | 0.18 | 1.23 | ||
| Clinical Group | Clinically unaffected | Ref | ||||
| Acute | 1.3 | 0.287 | 0.79 | 2.17 | ||
| Convalescent | 2.8 | <0.001 | 1.60 | 4.87 | ||
| Age | 1.07 | 0.024 | 1.00 | 1.13 | ||